Search
for
Sort by
Research 721–750 of 1000+
- The evaluation and management of hirsutism*1
- Metformin or Antiandrogen in the Treatment of Hirsutism in Polycystic Ovary Syndrome
- SERUM STEROIDS AND PITUITARY HORMONES IN FEMALE PUBERTY: A PARTLY LONGITUDINAL STUDY
- Treatment of Hirsutism With Spironolactone
- Hirsutism and acne in polycystic ovary syndrome
- Health-related quality of life in women with polycystic ovary syndrome: A comparison with the general population using the Polycystic Ovary Syndrome Questionnaire (PCOSQ) and the Short Form-36 (SF-36)
- Relationship Between Androgen Levels and Blood Pressure in Young Women With Polycystic Ovary Syndrome
- Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study
- A Prospective Study of the Prevalence of Nonclassical Congenital Adrenal Hyperplasia among Women Presenting with Hyperandrogenic Symptoms and Signs
- Global Adiposity Rather Than Abnormal Regional Fat Distribution Characterizes Women with Polycystic Ovary Syndrome
- Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes
- Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions
- The pathogenesis and treatment of polycystic ovary syndrome: What’s new?
- The influence of androgens on insulin resistance
- Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies
- Prevalence of polycystic ovary syndrome in unselected women from southern China
- A Simple Screening Approach for Assessing Community Prevalence and Phenotype of Polycystic Ovary Syndrome in a Semiurban Population in Sri Lanka
- Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome
- Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the National Institutes of Health 1990 criteria
- Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women
- A review of diagnosis and treatment of acne in adult female patients
- Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin
- Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
- Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management
- Treatment of Obstructive Sleep Apnea Improves Cardiometabolic Function in Young Obese Women with Polycystic Ovary Syndrome
- Metformin treatment of polycystic ovary syndrome improves health-related quality-of-life, emotional distress and sexuality
- Mediators of Inflammation in Polycystic Ovary Syndrome in Relation to Adiposity
- Risk of Psychiatric Disorders following Polycystic Ovary Syndrome: A Nationwide Population-Based Cohort Study
- Prevalence of Type II diabetes mellitus and insulin resistance in parents of women with polycystic ovary syndrome
- Androgen excess is the key element in polycystic ovary syndrome